Tyrosine Kinase Inhibitors Market

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface.

Tyrosine Kinase Inhibitors Market contains market size and forecasts of Tyrosine Kinase Inhibitors in global, including the following market information:

Global Tyrosine Kinase Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Tyrosine Kinase Inhibitors Market Sales, 2017-2022, 2023-2028, (K MT)

Global top five Tyrosine Kinase Inhibitors companies in 2021 (%)

The global Tyrosine Kinase Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

BCR-ABL Tyrosine Kinase Inhibitor Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Tyrosine Kinase Inhibitors include AstraZeneca, Pfizer, Novartis, Bristol-Myers Squibb, Bayer, Boehringer Ingelheim International, F. Hoffmann-La Roche, Johnson & Johnson and Eisai. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Tyrosine Kinase Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Tyrosine Kinase Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Tyrosine Kinase Inhibitors Market Segment Percentages, by Type, 2021 (%)

BCR-ABL Tyrosine Kinase Inhibitor

Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors

Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors

Global Tyrosine Kinase Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Tyrosine Kinase Inhibitors Market Segment Percentages, by Application, 2021 (%)

Chronic Myeloid Leukemia (CML)

Lung Cancer

Breast Cancer

Renal Cell Cancer

Others

Global Tyrosine Kinase Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Tyrosine Kinase Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Tyrosine Kinase Inhibitors revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Tyrosine Kinase Inhibitors revenues share in global market, 2021 (%)

Key companies Tyrosine Kinase Inhibitors sales in global market, 2017-2022 (Estimated), (K MT)

Key companies Tyrosine Kinase Inhibitors sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

AstraZeneca

Pfizer

Novartis

Bristol-Myers Squibb

Bayer

Boehringer Ingelheim International

F. Hoffmann-La Roche

Johnson & Johnson

Eisai